Healthcare provider profile · identity verified

Douglas M Romney, MD

Internal Medicine · MURRAY, UT · NPI 1427060342

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	551	162
Levothyroxine Sodium	Levothyroxine Sodium	497	123
Rosuvastatin Calcium	Rosuvastatin Calcium	484	133
Amlodipine Besylate	Amlodipine Besylate	422	110
Losartan Potassium	Losartan Potassium	350	96
Gabapentin	Gabapentin	336	113
Omeprazole	Omeprazole	266	85
Pantoprazole Sodium	Pantoprazole Sodium	248	76
Metformin Hcl Er	Metformin Hcl	232	65
Duloxetine Hcl	Duloxetine Hcl	214	47
Metformin Hcl	Metformin Hcl	204	60
Simvastatin	Simvastatin	186	55
Sertraline Hcl	Sertraline Hcl	185	57
Glimepiride	Glimepiride	175	51
Lisinopril	Lisinopril	160	49
Tramadol Hcl	Tramadol Hcl	153	32
Carvedilol	Carvedilol	151	47
Eliquis	Apixaban	144	33
Metoprolol Succinate	Metoprolol Succinate	144	45
Spironolactone	Spironolactone	134	40
Alendronate Sodium	Alendronate Sodium	131	38
Zolpidem Tartrate	Zolpidem Tartrate	126	23
Tamsulosin Hcl	Tamsulosin Hcl	124	40
Mounjaro	Tirzepatide	119	20
Pravastatin Sodium	Pravastatin Sodium	117	35
Potassium Chloride	Potassium Chloride	112	34
Trazodone Hcl	Trazodone Hcl	110	39
Montelukast Sodium	Montelukast Sodium	109	29
Furosemide	Furosemide	108	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	106	24
Estradiol	Estradiol	97	33
Alprazolam	Alprazolam	95	14
Allopurinol	Allopurinol	94	28
Celecoxib	Celecoxib	94	27
Finasteride	Finasteride	93	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	92	27
Escitalopram Oxalate	Escitalopram Oxalate	91	28
Ozempic	Semaglutide	90	12
Donepezil Hcl	Donepezil Hcl	88	24
Famotidine	Famotidine	85	26
Meloxicam	Meloxicam	84	30
Clopidogrel	Clopidogrel Bisulfate	83	22
Olmesartan Medoxomil	Olmesartan Medoxomil	83	28
Trulicity	Dulaglutide	75	15
Hydrochlorothiazide	Hydrochlorothiazide	72	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	19
Fluticasone Propionate	Fluticasone Propionate	67	31
Lorazepam	Lorazepam	66	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	65	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	65	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	64	20
Xarelto	Rivaroxaban	64	12
Clonazepam	Clonazepam	63	17
Irbesartan	Irbesartan	62	18
Jardiance	Empagliflozin	60	15
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	59	18
Mirtazapine	Mirtazapine	59	18
Citalopram Hbr	Citalopram Hydrobromide	58	16
Ropinirole Hcl	Ropinirole Hcl	58	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	16
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	55	18
Albuterol Sulfate Hfa	Albuterol Sulfate	54	27
Oxybutynin Chloride Er	Oxybutynin Chloride	53	18
Ezetimibe	Ezetimibe	49	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	18
Torsemide	Torsemide	48	15
Venlafaxine Hcl Er	Venlafaxine Hcl	47	suppressed
Synthroid	Levothyroxine Sodium	46	11
Benazepril Hcl	Benazepril Hcl	45	15
Lansoprazole	Lansoprazole	41	13
Pregabalin	Pregabalin	41	suppressed
Ibuprofen	Ibuprofen	38	12
Ondansetron Hcl	Ondansetron Hcl	38	16
Diclofenac Sodium	Diclofenac Sodium	36	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Risperidone	Risperidone	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Valacyclovir	Valacyclovir Hcl	33	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	11
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Ipratropium Bromide	Ipratropium Bromide	30	15
Triamcinolone Acetonide	Triamcinolone Acetonide	30	20
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	11
Azelastine Hcl	Azelastine Hcl	26	11
Buspirone Hcl	Buspirone Hcl	26	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Verapamil Er	Verapamil Hcl	25	suppressed
Diazepam	Diazepam	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Topiramate	Topiramate	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Cephalexin	Cephalexin	21	15
Raloxifene Hcl	Raloxifene Hcl	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Amoxicillin	Amoxicillin	18	15
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Eplerenone	Eplerenone	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Insulin Aspart Flexpen	Insulin Aspart	15	suppressed
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	15	suppressed
Potassium Citrate Er	Potassium Citrate	15	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Gemtesa	Vibegron	13	suppressed
Humalog Kwikpen U-200	Insulin Lispro	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Estrogel	Estradiol	12	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	12	suppressed
Atenolol	Atenolol	11	suppressed
Crestor	Rosuvastatin Calcium	11	suppressed
Glipizide	Glipizide	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error